logo

For the Inventor, By the Inventor

Stevenage, United Kingdom

Malcolm Clive Carter

This inventor holds 25 USPTO granted patents and 4 published patent applications and 1 EPO patent, primarily in Heterocyclic Compounds. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation, Arrow Therapeutics Limited. Active years: 1983-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Malcolm Clive Carter. Retrieved from https://idiyas.com/inventor/malcolm-clive-carter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 25 

% Patents Active = 64.0


Average Co-Inventor Count = 4.1

ph-index = 11

Forward Citations = 621(Granted Patents)


Location History:

  • Herts, GB (2002)
  • Ware Herts, GB (2012)
  • Ware, GB (1983 - 2013)
  • London, GB (2004 - 2014)
  • Stevenage, GB (1997 - 2015)

Company Filing History:

goldMedal8 out of 1,170 
 
Glaxo Group Limited
 patents
silverMedal8 out of 2,198 
 
Smithkline Beecham Corporation
 patents
bronzeMedal3 out of 4 
 
Arrow Therapeutics Limited
 patents
4. 2 out of 281 
 
Glaxo Wellcome Inc.
 patents
5. 2 out of 358 
 
Glaxosmithkline LLC
 patents
6. 1 out of 1,534 
 
Astrazeneca Ab
 patents
7. 1 out of 3,978 
 
Novartis Ag
 patents

Years Active: 1983-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Heteroaromatic Compounds
Protein Tyrosine Kinase Inhibitors
Benzodiazepine Derivatives
Pyrimidine Derivatives
Cyclooxygenase-2 Inhibitors
Biphenyl Derivatives
Fused Heterocyclic Compounds
Indoline Derivatives
Aminocyclopentane Esters
Pharmaceutical Compositions
Benzanilide Derivatives
25 patents (USPTO):Explore Patents
1. 9199973 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2015-12-01),
2. 8912205 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2014-12-16),
3. 8853204 - Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein (2014-10-07),
4. 8513262 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2013-08-20),
5. 8119630 - Benzodiazepine derivatives and pharmaceutical compositions containing them (2012-02-21),
6. 8008303 - Biphenyl derivatives and their use in treating hepatitis C (2011-08-30),
7. 7582624 - Benzodiazepine derivatives and pharmaceutical compositions containing them (2009-09-01),
8. 7109333 - Heterocyclic compounds (2006-09-19),
9. 7084148 - Substituted pyrimidines as selective cyclooxygenase-2 inhibitors (2006-08-01),
10. 7056928 - Pyrimidine derivatives as selective inhibitors of COX-2 (2006-06-06),
11. 6828320 - Heterocyclic compounds (2004-12-07),
12. 6780870 - Pyrimidine derivatives as selective inhibitors of COX-2 (2004-08-24),
13. 6727256 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2004-04-27),
14. 6723726 - Protein tyrosine kinase inhibitors (2004-04-20),
15. 6713485 - Heterocyclic compounds (2004-03-30),

Title: Malcolm Clive Carter - Innovative Inventor from Stevenage

Introduction: Malcolm Clive Carter is a renowned inventor hailing from Stevenage, Great Britain. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of innovation.

Latest Patents: Malcolm Clive Carter holds several patents in various industries, including technology, healthcare, and sustainable energy. His recent patents focus on enhancing efficiency and sustainability in everyday products.

Career Highlights: Throughout his career, Malcolm Clive Carter has been recognized for his innovative thinking and problem-solving skills. He has received numerous awards for his contributions to the field of invention and has been instrumental in bringing several products to market.

Collaborations: Malcolm Clive Carter has collaborated with leading companies and research institutions to bring his inventions to life. His ability to work across disciplines and industries has led to successful partnerships and groundbreaking innovations.

Conclusion: Malcolm Clive Carter's dedication to innovation and his relentless pursuit of creative solutions have solidified his reputation as a pioneering inventor in Stevenage and beyond. His work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…